Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-24

FDA Approved: PRASUGREL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Mylan Pharmaceuticals for prasugrel, enabling a generic prasugrel product. The indication covers reducing throm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)